Head/Neck Cancer

Top Story

Nivolumab benefit in advanced head and neck cancer maintained regardless of age

November 9, 2018
Meeting News

Cancer survivors likely to receive HPV vaccine after provider recommendation

November 5, 2018
ORLANDO, Fla. — A study presented at the AAP National Conference & Exhibition revealed that among young adult and adolescent cancer survivors, provider

Removal of ‘cancer’ label could reduce overdiagnosis, overtreatment of low-risk disease

October 26, 2018
Use of the term “cancer” at diagnosis may prompt individuals with low-risk lesions to choose aggressive treatment that could do more harm than good…
In the Journals Plus

Vaccine, nivolumab combination appears promising in recurrent HPV-related cancer

October 25, 2018
Treatment with a novel, synthetic, long-peptide HPV-16 vaccine plus nivolumab yielded promising response rates and survival outcomes among a small cohort of patients…
More Headlines »

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »

Baseball great Mike Schmidt became ‘concerned about dying’ after melanoma diagnosis

September 25, 2017
More »